Atomwise Announces Growing Portfolio of Joint Venture Companies
Published: Dec 21, 2020 Dec. 21, 2020 21:37 UTC Atomwise unveils a growing portfolio of emerging joint venture companies, with programs spanning oncology, immunology, infectious disease, neuroscience and clotting disorders. Atomwise CEO and joint venture companies are scheduled to speak at Informa's Biotech Showcase from January 11-15, 2021 during J.P. Morgan Healthcare Week. Atomwise, the leader in using artificial intelligence (AI) for small-molecule drug discovery, today unveiled its growing portfolio of emerging joint venture companies with research programs spanning oncology, immunol...
Source: biospace.com